Morgan Stanley Maintains Equal-Weight on Immunocore Holdings, Lowers Price Target to $42

Benzinga · 1d ago
Morgan Stanley analyst Sean Laaman maintains Immunocore Holdings (NASDAQ:IMCR) with a Equal-Weight and lowers the price target from $43 to $42.